Important information 博彩app软件下载app软件 the discontinuation of 博彩app软件下载

博彩app软件下载app软件下载 Myers Squibb has or is discontinuing 博彩app软件下载 (daclatasvir) in countries where the product is no longer routinely prescribed or there are other therapeutic options available. 博彩app软件下载 played a significant role in providing a new era of treatment, offering patients across the globe the potential for cure from chronic HCV infection.  New Hepatitis C treatments have built on the safety and efficacy profile of 博彩app软件下载 to offer shorter treatment durations and a reduced pill burden, and thus providing patients more options for a potential cure.  

Following the lapse / withdrawal of the marketing authorization in each country, the patents in that country will also be allowed to lapse. In the interim period between the lapse / withdrawal of a marketing authorization and patent expiry, 博彩app软件下载app软件下载 Myers Squibb will not enforce its 博彩app软件下载 patents in that country. This policy is specific for 博彩app软件下载 moving forward. 



技术支持 AI智能站群